JNJ
Johnson & Johnson
$260.30
0.50 (0.19%) Today
— up— down
Market Cap
$628.36B+50.7%
Revenue (TTM)
$96.72B+8.1%
Net Income (TTM)
$20.78B-7.8%
EPS (TTM)
8.62-7.8%
Shares Out
2.41B
2.41BP/E Ratio
29.81
29.81Forward P/E
20.74
20.74Dividend
$5.14 (2.06%)
$5.14 (2.06%)Ex-Dividend Date
May 26, 2026
May 26, 2026Open
$256.00
$256.00Previous Close
$259.80
$259.80Day Range
$255.26 – $261.41
$255.26 – $261.4152-Week Range
$172.70 – $274.90
$172.70 – $274.90Beta
0.20
0.20Volume
1.75M
1.75MAvg Volume
8.04M
8.04MAnalyst Rating
Buy
BuyExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About JNJ
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Related
News
N/AN/AN/AN/AN/A
What Johnson & Johnson (JNJ)'s OTTAVA FDA Win and Talc Deal Shift Mean For Shareholders
Yahoo · 1d ago
Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?
Yahoo · 1d ago
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
Yahoo · 1d ago
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
Yahoo · 1d ago
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Yahoo · 2d ago